The landscape of medical weight management in the Philippines has evolved rapidly as we enter 2026. Two names dominate the conversation: Mounjaro  (Tirzepatide) and Wegovy   (Semaglutide) . Both are FDA-approved, once-weekly injectables that have changed the lives of thousands, but they are not identical. As patients in Bonifacio Global City  and across Taguig  look for the most effective way to reach their health goals, the debate often centers on which medication delivers s

As 2026 begins, many are embarking on transformative health journeys. With the help of advanced programs like Shape Ultra  and medications like Tirzepatide , achieving significant weight loss has become more accessible than ever. However, rapid fat loss often reveals an unintended aesthetic side effect: a loss of facial volume and structural support. When we lose weight systemically, we don't just lose fat from our midsections; we lose it from the protective pads in our cheek